Evidence map›Paper›PMID 35388072›Full record

ArticleScientific reports2022

Prolonged and extended impacts of SARS-CoV-2 on the olfactory neurocircuit.

Megumi Kishimoto-Urata, Shinji Urata, Ryoji Kagoya, Fumiaki Imamura, Shin Nagayama, Rachel A Reyna, Junki Maruyama, Tatsuya Yamasoba, Kenji Kondo, Sanae Hasegawa-Ishii and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Combination antiviral and anti-inflammatory therapy mitigates persistent neurological deficits in mice post SARS-CoV-2 infection.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Mechanisms of COVID-19-associated olfactory dysfunction.Neuropathology and applied neurobiology · 2024
    Review
  14. Review
  15. Article
  16. Article
  17. Mechanisms of long COVID: An updated review.Chinese medical journal pulmonary and critical care medicine · 2023
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Megumi Kishimoto-Urata *Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.
Shinji Urata *Department of Otolaryngology, University of Texas Medical Branch, Galveston, TX, USA.
Ryoji KagoyaDepartment of Otolaryngology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Fumiaki ImamuraDepartment of Pharmacology, Penn State College of Medicine, Hershey, PA, USA.
Shin NagayamaDepartment of Neurobiology and Anatomy, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA.
Rachel A ReynaDepartment of Pathology, University of Texas Medical Branch, Galveston, TX, USA.
Junki MaruyamaDepartment of Pathology, University of Texas Medical Branch, Galveston, TX, USA.
Tatsuya YamasobaDepartment of Otolaryngology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Kenji KondoDepartment of Otolaryngology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. kondok-tky@umin.ac.jp.
Sanae Hasegawa-IshiiPathology Research Team, Kyorin University, Tokyo, Japan. sanae_ishii@ks.kyorin-u.ac.jp.
Slobodan PaesslerDepartment of Otolaryngology, University of Texas Medical Branch, Galveston, TX, USA. slpaessl@utmb.edu.
The University of Texas Medical Branch at Galveston · USThe University of Tokyo · JPKyorin University · JPPenn State Milton S. Hershey Medical Center · US

Funding

Viral factors responsible for Lassa virus pathogenicityR00AI156012 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI MARUYAMA, JUNKI · 2023 to 2024
$498k
Viral factors responsible for Lassa virus pathogenicityK99AI156012 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI MARUYAMA, JUNKI · 2021 to 2022
$177k
NIAID NIH HHS K99 AI156012NIAID NIH HHS R00 AI156012
6 · The paper itself

Abstract

The impact of SARS-CoV-2 on the olfactory pathway was studied over several time points using Syrian golden hamsters. We found an incomplete recovery of the olfactory sensory neurons, prolonged activation of glial cells in the olfactory bulb, and a decrease in the density of dendritic spines within the hippocampus. These data may be useful for elucidating the mechanism underlying long-lasting olfactory dysfunction and cognitive impairment as a post-acute COVID-19 syndrome.

Indexed as

COVID-19Olfactory Receptor NeuronsAnimalsCricetinaeOlfactory MucosaPost-Acute COVID-19 SyndromeSARS-CoV-2

Identifiers

PMID35388072
PMCPMC8987081
OpenAlexW4225712212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.